Anticonvulsive Properties of Cannabidiol in a Model of Generalized Seizure Are Transient Receptor Potential Vanilloid 1 Dependent

Introduction: Highly purified cannabidiol (CBD) (approved as Epidiolex(®) in the United States) has demonstrated efficacy with an acceptable safety profile in patients with Lennox–Gastaut or Dravet syndrome in four randomized controlled trials. CBD possesses affinity for many target classes with fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Gray, Royston A., Stott, Colin G., Jones, Nicholas A., Di Marzo, Vincenzo, Whalley, Benjamin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347071/
https://www.ncbi.nlm.nih.gov/pubmed/32656346
http://dx.doi.org/10.1089/can.2019.0028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347071/
https://www.ncbi.nlm.nih.gov/pubmed/32656346
http://dx.doi.org/10.1089/can.2019.0028

Ejemplares similares